Institution
National Cancer Institute
Also known as: Institut National du Cancer · Instituto Nacional del Cáncer · NCI
- 10running trials
- 7closed trials
- 136,860publications (OpenAlex)
Running trials
Not yet recruiting
Recruiting
Recruiting
Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer
Recruiting
Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors
Recruiting
Active, not recruiting
Bicalutamide Implants (Biolen) With Radiation Therapy in Patients With Localized Prostate Cancer
Active, not recruiting
Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma
Active, not recruiting
Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Melanoma2 recruiting
- Aplastic anaemia1 recruiting
- Childhood cancers1 recruiting
- Lung cancer1 recruiting
- Prostate cancer1 recruiting
Closed trials
Terminated
Terminated
A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer
Completed
ProAgio in Previously Treated Advanced Pancreatic Cancer and Other Solid Tumor Malignancies
Terminated
A Study of NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma
Recruiting
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
Completed
Completed
Trial of Panobinostat in Children With Diffuse Intrinsic Pontine Glioma
Registry name variants (2)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
National Cancer Institute
Bethesda, Maryland 20814
15 trials
National Cancer Institute
Rockville, Maryland 20850
2 trials
Conditions
Diseases this institution publishes on or runs trials for.
- Prostate cancer160 works · 3 trials
- Lung cancer144 works · 4 trials
- Liver and biliary tract cancer97 works · 2 trials
- Melanoma95 works · 2 trials
- Colorectal cancer88 works · 1 trial
- HIV85 works · 0 trials
- Sarcoma76 works · 2 trials
- Ovarian cancer62 works · 4 trials
- Glioblastoma57 works · 0 trials
- Kidney cancer56 works · 1 trial
- Cervical cancer55 works · 1 trial
- Childhood cancers47 works · 4 trials
- Triple-negative breast cancer46 works · 2 trials
- Pancreatic cancer45 works · 2 trials
- Bladder cancer41 works · 0 trials
- Thyroid cancer39 works · 0 trials
- Hodgkin lymphoma37 works · 0 trials
- Neuroendocrine tumours35 works · 0 trials
- Acute lymphoblastic leukaemia34 works · 0 trials
- Acute myeloid leukaemia31 works · 0 trials
- Neuroblastoma31 works · 0 trials
- Neurofibromatosis type 126 works · 0 trials
- Diffuse large B-cell lymphoma26 works · 0 trials
- Endometrial cancer21 works · 0 trials
- Mesothelioma19 works · 2 trials
- Myelodysplastic syndromes17 works · 0 trials
- Metastatic breast cancer16 works · 0 trials
- Head and neck cancer15 works · 1 trial
- Brain metastases15 works · 0 trials
- Sickle cell disease12 works · 0 trials
Institution data: ROR 040gcmg81 (CC0-1.0)Updated 15 Nov 2026